BIOMARIN PHARMACEUTICAL INC Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for June 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | YOUNG WILLIAM D | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 1,100 | 0 | 11,875 | 10.8 K to 11.9 K (+10.21 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 1,100 | 0 | 6,325 | 5.2 K to 6.3 K (+21.05 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Grant | A | 0.00 | 1,100 | 0 | 25,250 | 24.2 K to 25.3 K (+4.55 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 1,100 | 0 | 22,500 | 21.4 K to 22.5 K (+5.14 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 1,100 | 0 | 12,900 | 11.8 K to 12.9 K (+9.32 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Grant | A | 0.00 | 1,100 | 0 | 31,250 | 30.2 K to 31.3 K (+3.65 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 1,100 | 0 | 20,625 | 19.5 K to 20.6 K (+5.63 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 1,100 | 0 | 26,250 | 25.2 K to 26.3 K (+4.37 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | BATE KENNETH | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | BATE KENNETH | Director | Grant | A | 0.00 | 1,100 | 0 | 11,875 | 10.8 K to 11.9 K (+10.21 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 122.30 | 1,649 | 201,669 | 28,229 | 29.9 K to 28.2 K (-5.52 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 120.46 | 1,801 | 216,948 | 29,878 | 31.7 K to 29.9 K (-5.69 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 120.46 | 522 | 62,880 | 11,926 | 12.4 K to 11.9 K (-4.19 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 122.32 | 1,864 | 228,001 | 72,846 | 74.7 K to 72.8 K (-2.49 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 120.46 | 2,036 | 245,257 | 74,710 | 76.7 K to 74.7 K (-2.65 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Gift | G | 0.00 | 120 | 0 | 67,618 | 67.7 K to 67.6 K (-0.18 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Payment of Exercise | F | 120.46 | 1,488 | 179,244 | 67,738 | 69.2 K to 67.7 K (-2.15 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 120.46 | 6,640 | 799,854 | 229,254 | 235.9 K to 229.3 K (-2.81 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 20,000 | |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 0.00 | 7,500 | 0 | 25,000 | |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 0.00 | 5,000 | 0 | 99,067 | 94.1 K to 99.1 K (+5.32 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 0.00 | 7,500 | 0 | 94,067 | 86.6 K to 94.1 K (+8.66 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 1,506 | 0 | 29,176 | 27.7 K to 29.2 K (+5.44 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Gift | G | 0.00 | 1,506 | 0 | 99,500 | 101 K to 99.5 K (-1.49 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 120.46 | 1,644 | 198,036 | 101,056 | 102.7 K to 101.1 K (-1.60 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 122.35 | 1,362 | 166,646 | 35,605 | 37 K to 35.6 K (-3.68 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 120.46 | 1,488 | 179,244 | 36,967 | 38.5 K to 37 K (-3.87 %) |
Jun 03 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 124.16 | 3,945 | 489,811 | 31,679 | 35.6 K to 31.7 K (-11.07 %) |
Jun 03 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 126.15 | 1,578 | 199,065 | 35,624 | 37.2 K to 35.6 K (-4.24 %) |
Jun 03 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 125.57 | 4,305 | 540,579 | 37,202 | 41.5 K to 37.2 K (-10.37 %) |
Jun 03 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 125.57 | 308 | 38,676 | 12,448 | 12.8 K to 12.4 K (-2.41 %) |
Jun 03 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 123.76 | 377 | 46,657 | 38,455 | 38.8 K to 38.5 K (-0.97 %) |
Jun 03 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Payment of Exercise | F | 125.57 | 413 | 51,860 | 38,832 | 39.2 K to 38.8 K (-1.05 %) |